Why whey? Camel whey protein as a new dietary approach to the management of free radicals and for the treatment of different health disorders

سال انتشار: 1396
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 130

فایل این مقاله در 12 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-20-4_001

تاریخ نمایه سازی: 28 مهر 1400

چکیده مقاله:

The balance between free radicals and antioxidants is an important factor for maintaining health and slowing disease progression. The use of antioxidants, particularly natural antioxidants, has become an important strategy for dealing with this cause of widespread diseases. Natural antioxidants have been used as therapeutic tools against many diseases because they are safe, effective, and inexpensive and are among the most commonly used adjuvants in the treatment of several diseases. Camel whey protein (CWP) is considered a strong natural antioxidant because it decreases oxidative stress, enhances immune system function, and increases glutathione levels. The structure of CWP is very similar to that of other types of whey protein from different types of milk. CWP contains many components, such as lactoferrin (LF), lactalbumin, lactoglobulins, lactoperoxidase, and lysozyme, and is rich in immunoglobulins. However, in contrast to other WPs, CWP lacks β-lactoglobulin, the main cause of milk allergies in children. The components of CWP have many beneficial effects, including stimulation of both innate and adaptive immunity and anti-inflammatory, anticancer, antibacterial, and antiviral activities. Recently, it has been shown that CWP and its unique components can facilitate the treatment of impaired diabetic wound healing. However, the molecular mechanisms underlying the protective effects of CWP in human and other animal disorders are not fully understood. Therefore, the current review presents a concise summary of the scientific evidence of the beneficial effects of CWP to support its therapeutic use in disease treatment and nutritional intervention.

نویسندگان

Gamal Badr

Zoology Department, Faculty of Science, Assiut University, ۷۱۵۱۶ Assiut, Egypt

Nancy Ramadan

Zoology Department, Faculty of Science, Assiut University, ۷۱۵۱۶ Assiut, Egypt

Leila Sayed

Zoology Department, Faculty of Science, Assiut University, ۷۱۵۱۶ Assiut, Egypt

Badr M Badr

Department of Radiation Biology, National Centre for Radiation Research and Technology (NCRRT), Atomic Energy Authority, Egypt

Hossam M Omar

Zoology Department, Faculty of Science, Assiut University, ۷۱۵۱۶ Assiut, Egypt

Zeliha Selamoglu

Department of Biology, Faculty of Arts and Sciences, Nigde University, Nigde, Turkey

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • ۱.Ebaid H, Badr G, Metwalli A. Immunoenhancing property of dietary ...
  • ۲.Badr G, Badr BM, Mahmoud MH, Mohany M, Rabah DM, ...
  • ۳.Badr G. Camel whey protein enhances diabetic wound healing in ...
  • ۴.Badr G. Supplementation with undenatured whey protein during diabetes mellitus ...
  • ۵.Badr G, Mohany M, Metwalli A. Effects of undenatured whey ...
  • ۶.Badr G, Ebaid H, Mohany M, Abuelsaad AS. Modulation of ...
  • ۷.Mohany M, Badr BM, Mahmoud MH, Garraud O, Badr G. ...
  • ۸.Power O, Jakeman P, FitzGerald R. Antioxidative peptides: Enzymatic production, ...
  • ۹.Marshall K. Therapeutic applications of whey protein. Altern Med Rev ...
  • ۱۰.El-Hatmi H, Girardet JM, Gaillard JL, Yahyaoui MH, Attia H. ...
  • ۱۱.Salami M, Moosavi-Movahedi AA, Ehsani MR, Yousefi R, Haertlé T, ...
  • ۱۲.Abdel-Aziem SH, Hassan AM, Abdel-Wahhab MA. Dietary supplementation with whey ...
  • ۱۳.Sousa GT, Lira FS, Rosa JC, de Oliveira EP, Oyama ...
  • ۱۴.Ebaid H, Ahmed OM, Mahmoud AM, Ahmed RR. Limiting prolonged ...
  • ۱۵.Khaskheli M, Arain M, Chaudhry S, Soomro A, Qureshi T. ...
  • ۱۶.Kappeler SR, Heuberger C, Farah Z, Puhan Z. Expression of ...
  • ۱۷.Elagamy EI. Effect of heat treatment on camel milk proteins ...
  • ۱۸.Lucas DO. Breakthrough technology produces concentrated whey protein with bioactive ...
  • ۱۹.Laleye L, Jobe B, Wasesa A. Comparative study on heat ...
  • ۲۰.Hinz K, O'Connor PM, Huppertz T, Ross RP, Kelly AL. ...
  • ۲۱.El-Agamy EI, Nawar M, Shamsia SM, Awad S, Haenlein GF. ...
  • ۲۲.Kappeler S, Farah Z, Puhan Z. Alternative splicing of lactophorin ...
  • ۲۳.Cohen MS, Britigan BE, French M, Bean K. Preliminary observations ...
  • ۲۴.Harmsen MC, Swart PJ, de Béthune MP, Pauwels R, De ...
  • ۲۵.Sanchez L, Calvo M, Brock JH. Biological role of lactoferrin. ...
  • ۲۶.Conesa C, Sánchez L, Rota C, Pérez MD, Calvo M, ...
  • ۲۷.Gauthier SF, Pouliot Y, Saint-Sauveur D. Immunomodulatory peptides obtained by ...
  • ۲۸.Rusu D, Drouin R, Pouliot Y, Gauthier S, Poubelle PE. ...
  • ۲۹.Micke P, Beeh K, Schlaak J, Buhl R. Oral supplementation ...
  • ۳۰.Krissansen GW. Emerging health properties of whey proteins and their ...
  • ۳۱.Beaulieu J, Dupont C, Lemieux P. Whey proteins and peptides: ...
  • ۳۲.Loss G, Apprich S, Waser M, Kneifel W, Genuneit J, ...
  • ۳۳.Castro G, Maria D, Bouhallab S, Sgarbieri V. In vitro ...
  • ۳۴.Ebaid H, Salem A, Sayed A, Metwalli A. Whey protein ...
  • ۳۵.Ebaid H. Promotion of immune and glycaemic functions in streptozotocin-induced ...
  • ۳۶.Ebaid H. Neutrophil depletion in the early inflammatory phase delayed ...
  • ۳۷.Walzem R, Dillard C, German J. Whey components: Millennia of ...
  • ۳۸.Low PPL, Rutherford KJ, Gill HS, Cross ML. Effect of ...
  • ۳۹.Faloon PW, Chou DHC, Forbeck EM, Walpita D, Morgan B, ...
  • ۴۰.Bounous G, Batist G, Gold P. Immunoenhancing property of dietary ...
  • ۴۱.Belokrylov G, Popova OY, Molchanova I, Sorochinskaya E, Anokhina V. ...
  • ۴۲.Kawasaki H. Comparative studies on proteodermatan sulfate of bovine gastrointestinal ...
  • ۴۳.Marchetti M, Pisani S, Antonini G, Valenti P, Seganti L, ...
  • ۴۴.Wong CW, Watson DL. Immunomodulatory effects of dietary whey proteins ...
  • ۴۵.Machnicki M, Zimecki M, Zagulski T. Lactoferrin regulates the release ...
  • ۴۶.Ögünç V, Manukyan Cingi, Eksioglu-Demiralp, Aktan Ö, Yalçın S. Dietary ...
  • ۴۷.Ajarem J, Allam AA, Ebaid H, Maodaa SN, AL-Sobeai SM, ...
  • ۴۸.Takamiya M, Fujita S, Saigusa K, Aoki Y. Simultaneous detections ...
  • ۴۹.Lin Q, Fang D, Fang J, Ren X, Yang X, ...
  • ۵۰.Mori R, Kondo T, Ohshima T, Ishida Y, Mukaida N. ...
  • ۵۱.Black E, Vibe-Petersen J, Jorgensen LN, Madsen SM, Ågren MS, ...
  • ۵۲.Zhang Z, Zhao M, Wang J, Ding Y, Dai X, ...
  • ۵۳.Mahmoud MH, Badr G, El Shinnawy NA. Camel whey protein ...
  • ۵۴.Habib HM, Ibrahim WH, Schneider-Stock R, Hassan HM. Camel milk ...
  • ۵۵.Papenburg R, Bounous G, Fleiszer D, Gold P. Dietary milk ...
  • ۵۶.Bounous G, Batist G, Gold P. Whey proteins in cancer ...
  • ۵۷.McIntosh GH, Regester GO, Le Leu RK, Royle PJ, Smithers ...
  • ۵۸.Hakkak R, Korourian S, Shelnutt SR, Lensing S, Ronis MJ, ...
  • ۵۹.Bounous G. Whey protein concentrate (wpc) and glutathione modulation in ...
  • ۶۰.Hakkak R, Korourian S, Ronis MJ, Johnston JM, Badger TM. ...
  • ۶۱.Zimecki M, Wlaszczyk A, Wojciechowski R, Dawiskiba J, Kruzel, M. ...
  • ۶۲.Guimont C, Marchall E, Girardet JM, Linden G. Biologically active ...
  • ۶۳.Morales A, Miranda M, Sanchez-Reyes A, Biete A, Fernandez-Checa JC. ...
  • ۶۴.Friesen C, Kiess Y, Debatin KM. A critical role of ...
  • ۶۵.Nukumi N, Iwamori T, Kano K, Naito K, Tojo H. ...
  • ۶۶.Tsuda H, Miyamoto T. Angiotensin i‐converting enzyme inhibitory peptides in ...
  • ۶۷.Smith CG, Vane JR. The discovery of captopril. FASEB J ...
  • ۶۸.AlhajOA KA, Peters A. The effect of bifid bacterium lactis ...
  • ۶۹.López-Fandiño R, Otte J, Van Camp J. Physiological, chemical and ...
  • ۷۰.Li H, Papadopoulos V. Peripheral-type benzodiazepine receptor function in cholesterol ...
  • ۷۱.Seelig A, Seelig J. In interaction of drugs and peptides ...
  • ۷۲.Agrawal R, Budania S, Sharma P, Gupta R, Kochar D, ...
  • ۷۳.Agrawal RP, Saran S, Sharma P, Gupta RP, Kochar DK, ...
  • ۷۴.Sanz Fernandez MV, Pearce SC, Mani V, Gabler NK, Metzger ...
  • ۷۵.El Sayed I, Ruppanner R, Ismail A, Champagne CP, Assaf ...
  • ۷۶.Ochoa TJ, Cleary TG. Effect of lactoferrin on enteric pathogens. ...
  • ۷۷.Benkerroum N. Antimicrobial activity of lysozyme with special relevance to ...
  • ۷۸.Konuspayeva G, Faye B, Loiseau G, Levieux D. Lactoferrin and ...
  • ۷۹.Hara K, Ikeda M, Saito S, Matsumoto S, Numata K, ...
  • ۸۰.Redwan ERM, Tabll A. Camel lactoferrin markedly inhibits hepatitis c ...
  • ۸۱.Håkansson A, Svensson M, Mossberg AK, Sabharwal H, Linse S, ...
  • ۸۲.Benkerroum N, Mekkaoui M, Bennani N, Hidane K. Antimicrobial activity ...
  • ۸۳.Jrad Z, El Hatmi H, Adt I, Girardet JM, Cakir-Kiefer ...
  • ۸۴.EL-Fakharany EM, Abedelbaky N, Haroun BM, Sánchez L, Redwan NA, ...
  • ۸۵.Esmail ME, Ashraf T, El WA, Bakry MH, El-Rashdy MR. ...
  • ۸۶.Liao Y, El-Fakkarany E, Lönnerdal B, Redwan EM. Inhibitory effects ...
  • ۸۷.Arnold RR, Russell JE, Champion WJ, Brewer M, Gauthier JJ. ...
  • ۸۸.Crouch S, Slater K, Fletcher J. Regulation of cytokine release ...
  • ۸۹.Hashizume S, Kuroda K, Murakami H. Identification of lactoferrin as ...
  • ۹۰.Legrand D, Pierce A, Elass E, Carpentier M, Mariller C, ...
  • ۹۱.Redwan EM, EL-Fakharany EM, Uversky VN, Linjawi MH. Screening the ...
  • ۹۲.EL-Fakharany EM, Sánchez L, Al-Mehdar HA, Redwan EM. Effectiveness of ...
  • ۹۳.Holt LJ, Herring C, Jespers LS, Woolven BP, Tomlinson IM. ...
  • ۹۴.Bonkovsky HL, Banner BF, Rothman AL. Iron and chronic viral ...
  • ۹۵.Farinati F, Cardin R, De Maria N, Della Libera G, ...
  • ۹۶.Saltanat H, Li H, Xu Y, Wang J, Liu F, ...
  • ۹۷.Ikeda M, Sugiyama K, Tanaka T, Tanaka K, Sekihara H, ...
  • ۹۸.Berkhout B, van Wamel JL, Beljaars L, Meijer DK, Visser ...
  • ۹۹.Pietrantoni A, Di Biase AM, Tinari A, Marchetti M, Valenti ...
  • ۱۰۰.Van der Strate B, Beljaars L, Molema G, Harmsen M, ...
  • ۱۰۱.Copreni E, Castellani S, Palmieri L, Penzo M, Conese M. ...
  • ۱۰۲.Leistner CM, Gruen‐Bernhard S, Glebe D. Role of glycosaminoglycans for ...
  • ۱۰۳.Spear PG. Herpes simplex virus: Receptors and ligands for cell ...
  • ۱۰۴.Sapp M, Bienkowska‐Haba M. Viral entry mechanisms: Human papillomavirus and ...
  • ۱۰۵.Akhtar J, Shukla D. Viral entry mechanisms: Cellular and viral ...
  • ۱۰۶.Cocquerel L, Voisset C, Dubuisson J. Hepatitis c virus entry: ...
  • ۱۰۷.Schulze A, Gripon P, Urban S. Hepatitis b virus infection ...
  • ۱۰۸.Belting M. Heparan sulfate proteoglycan as a plasma membrane carrier. ...
  • ۱۰۹.Burckhardt CJ, Greber UF. Virus movements on the plasma membrane ...
  • ۱۱۰.Selinka HC, Giroglou T, Sapp M. Analysis of the infectious ...
  • ۱۱۱.Beleid R, Douglas D, Kneteman N, Kaur K. Helical peptides ...
  • ۱۱۲.Gifford JL, Ishida H, Vogel HJ. Structural characterization of the ...
  • ۱۱۳.Lin Q, Fang D, Hou X, Le Y, Fang J, ...
  • ۱۱۴.Zhang J, Mulvenon A, Makarov E, Wagoner J, Knibbe J, ...
  • ۱۱۵.Martin F, Volpari C, Steinkuhler C, Dimasi N, Brunetti M, ...
  • ۱۱۶.Lauwereys M, Ghahroudi MA, Desmyter A, Kinne, J, Hölzer W, ...
  • ۱۱۷.Davies MJ, Hawkins CL, Pattison DI, Rees MD. Mammalian heme ...
  • ۱۱۸.Redwan EM, Almehdar HA, EL-Fakharany EM, Baig AWK, Uversky VN. ...
  • ۱۱۹.Courtois P, Van Beers D, De Foor M, Mandelbaum I, ...
  • ۱۲۰.Mikola H, Waris M, Tenovuo J. Inhibition of herpes simplex ...
  • ۱۲۱.Yamaguchi Y, Semmel M, Stanislawski L, Strosberg A, Stanislawski M. ...
  • نمایش کامل مراجع